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Abstract
Malarial infection is associated with complex immune and erythropoietic responses in the host. A quantitative
understanding of these processes is essential to help inform malaria therapy and for the design of effective vaccines. In
this study, we use a statistical model-fitting approach to investigate the immune and erythropoietic responses in
Plasmodium chabaudi infections of mice. Three mouse phenotypes (wildtype, T-cell-deficient nude mice, and nude mice
reconstituted with T-cells taken from wildtype mice) were infected with one of two parasite clones (AS or AJ). Under a
Bayesian framework, we use an adaptive population-based Markov chain Monte Carlo method and fit a set of dynamical
models to observed data on parasite and red blood cell (RBC) densities. Model fits are compared using Bayes’ factors and
parameter estimates obtained. We consider three independent immune mechanisms: clearance of parasitised RBCs (pRBC),
clearance of unparasitised RBCs (uRBC), and clearance of parasites that burst from RBCs (merozoites). Our results suggest
that the immune response of wildtype mice is associated with less destruction of uRBCs, compared to the immune response
of nude mice. There is a greater degree of synchronisation between pRBC and uRBC clearance than between either
mechanism and merozoite clearance. In all three mouse phenotypes, control of the peak of parasite density is associated
with pRBC clearance. In wildtype mice and AS-infected nude mice, control of the peak is also associated with uRBC
clearance. Our results suggest that uRBC clearance, rather than RBC infection, is the major determinant of RBC dynamics
from approximately day 12 post-innoculation. During the first 2–3 weeks of blood-stage infection, immune-mediated
clearance of pRBCs and uRBCs appears to have a much stronger effect than immune-mediated merozoite clearance.
Upregulation of erythropoiesis is dependent on mouse phenotype and is greater in wildtype and reconstitited mice. Our
study highlights the informative power of statistically rigorous model-fitting techniques in elucidating biological systems.
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Introduction
Malarial infection of humans is a major cause of morbidity and
mortality, continuing to cause around 250 million cases and close
to a million deaths annually [1]. The vast majority of severe cases
and deaths are due to Plasmodium falciparum, which is endemic in
most of sub-Saharan Africa and other tropical areas [2]. Although
there is no simple relationship between the pathogenic processes
and clinical syndromes, disease only begins once the asexual
parasite begins to multiply within the host’s red blood cells (RBCs)
[3]. The asexual dynamics depend on a complex interaction
between the malaria parasite and the host’s immune and
erythropoetic responses [4]. Experimental methods have helped
elucidate key aspects of this interaction. Such factors include the
parasite’s destruction of RBCs due to reproduction [5,6], immune-
mediated clearance of merozoites and parasitised RBCs (pRBC)
[7,8], and immune-mediated clearance of unparasitised RBCs
(uRBC). In particular, there is evidence that loss of uRBCs is
responsible for the vast majority of the anaemia [9–11].
Suppression of RBC production (dyserythropoiesis) during the
acute phase may also contribute to anaemia [12,13], although
recent modelling suggests that, overall, the level of erythropoiesis
increases during malaria infection [8,9,14].
A full understanding of the infection dynamics requires
quantitative analysis of the relative importance of the contributory
factors [3]. Such an assessment is vital to help inform malaria
treatment and intervention programmes [8,15,16]. In particular,
the design of effective vaccines and immunotherapies depends
largely on our understanding of the innate and adaptive immune
responses [2,17]. In this context, rodent malaria models allow a
highly replicable, highly controlled experiment. Although there
are important differences between rodent and human malarias, a
quantitative understanding of the rodent system, where we can
control both host and parasite genetics, should help our under-
standing of the human case in which controlled experiments are
unethical.
As in other areas of science, mathematical models can be used
to make inferences about complex dynamical systems by fitting
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them to data. This approach allows us to formally and
quantitatively test and compare competing hypotheses, and to
make quantitative predictions for future empirical testing. It is the
most powerful and rapid way of culling possible, but incorrect,
hypotheses. In the mathematical modelling literature on malaria,
there are a number of studies that quantitatively fit models to data
[6,8,9,14,15,18–22]. However, the poorly developed statistical,
diagnostic and computational methodologies of fitting nonlinear
dynamical models to noisy data (see [23] and Discussion) meant
that these studies had to focus on particular aspects of the host-
pathogen system in isolation. The method used was maximum
likelihood. Its application to nonlinear systems is problematic
because the nonlinearities create complex multi-dimensional
likelihood surfaces. Search algorithms easily become trapped in
local maxima, leading to false inferences [24]. Even if one is
reasonably sure of having found the global maximum, evaluating
parameter confidence intervals and covariances is computationally
expensive and laborious, and computing predictive intervals
practically impossible [25].
Recent developments in adaptive, population-based Markov
chain Monte Carlo (McMC) methods overcome all of the problems
associated with maximum likelihood [24,26–30]. The use of a
Bayesian framework enables us to incorporate prior knowledge and
uncertainty about the parameters. It allows us to quantify our
relative belief in one model predicting the data over another, rather
than accepting and rejecting models using conventional, but
arbitrary, cut-offs. In order to use Bayesian statistics, we need to
know the structure and variance of the measurement errors.
Fortunately, these are known for our data sets.
In this study we develop a set of models to test competing
hypotheses describing the asexual stage of the malaria parasite. We
fit the models to a set of data on Plasmodium chabaudi infections [31]
using an adaptive McMC algorithm. We provide parameter
estimates, examine differences between mouse and parasite strains,
and make quantitative predictions about the immune and
erythropoietic systems’ dynamics, and their effects on the RBC
population. In modelling the asexual dynamics, there are three
general processes we need to consider: (i) the infection of RBCs, (ii)
the immune response, and (iii) the response of the erythropoietic
system to malaria-induced anaemia.
The immune system’s response to malaria is exceedingly complex
and there is still much to learn about it qualitatively, let alone
quantitatively [17]. Mathematical models have generally repre-
sented the immune response either as a single variable functionally
linked to parasite density, or as separate innate and adaptive
components [8,21,32–35]. The model of Recker et al. (2004) further
discriminates, on the basis of human serologic data, between short-
term, partially cross-reactive immune responses and long-term
specific responses [36]. These models have given valuable insights
into the immune dynamics, but it is important to acknowledge that
the immune response consists of multiple arms, each targeting
different aspects of the parasite [2]. Here we model the immune
system as time-dependent immune-mediated clearance rates of
merozoites, pRBCs and uRBCs. This allows us to bypass the debate
about the highly interdependent innate and adaptive arms of the
immune response, i.e., when they are activated, what they target,
and how they develop over time, and instead focus on the functional
consequences in terms of the infection dynamics.
We also draw attention to a key aspect of malaria asexual
reproduction universally ignored in previous modelling studies. It
is established that individual RBCs may be parasitised by more
than one merozoite. Multiply-parasitised RBCs are often observed
in experiments, but it is not known whether their subsequent
behaviour is the same as that of singly-parasitised RBCs; previous
models have generally assumed that their dynamics are identical.
Here we test that assumption. In particular, we test whether
multiply-parasitised RBCs have a greater death rate than other
RBCs, and whether they produce a greater number of merozoites
than singly-parasitised cells.
Materials and Methods
Previous experimental data
We used data obtained from a previous experiment [31]. Briefly,
three different mice phenotypes were infected with either of two
genetically distinct clones of Plasmodium chabaudi (AS or AJ). Both
clones were originally isolated from thicket rats (Thamnomys rutilans)
in the Central African Republic [37]. The AS clone is associated
with a lower peak density relative to AJ; it also has lower virulence,
as measured by anaemia and weight loss [38]. Three different
phenotypes of BALB/c mice were used: (i) wildtype mice; (ii) nu/nu
mice (‘‘nude mice’’; Harlan UK); and (iii) nude mice reconstituted
with T cells taken from wildtype mice. The mutation nu is a recessive
mutation that blocks the development of the thymus. Nude mice
therefore lack mature T cells, whereas heterozygotes (nu/+) have a
normal immune system [39]. Nude and reconstituted mice are
smaller than the wildtype and are hairless.
Mice of each phenotype (wildtype, nude, reconstituted) were
innoculated with 105 pRBCs of either AS or AJ. This gave six
treatment groups. There were seven mice in both treatment groups
for nude mice, and six mice in each treatment group for
reconstituted and wildtype mice. Measurements of RBC and
parasite density were taken on days 0, 2, 4, and then daily until day
18 when the experiment was terminated. Parasite density was
measured daily at 08:00 hrs using quantitative PCR, at which point
the asexual merozoites have yet to replicate within pRBCs. Both
RBC and parasite densities are expressed in terms of the number
per microlitre (ml) of blood. Full details of the experimental methods
are given in [31]. We removed a single data point from one of the
reconstituted AJ-infected replicates. This mouse had much lower
parasite density on day 14 than all the other mice. The data point
was therefore considered to be an outlier.
Author Summary
Malaria is a disease caused by a protozoan parasite of the
genus Plasmodium. Every year there are around 250 million
human cases of malaria, resulting in around a million
deaths. Most of the severe cases and deaths are due to
Plasmodium falciparum, which is endemic in much of sub-
Saharan Africa and other tropical areas. The pathology of
malaria is related to the asexual stage of the parasite.
Understanding the infection dynamics during this stage is
therefore essential to inform malaria treatment and
vaccine design. Experimental infections of rodents repre-
sent an important first step towards understanding the
more complicated human infections. We developed a
series of models representing different hypotheses about
the main processes regulating the infection dynamics
during the asexual stage. Models were fit to data on
Plasmodium chabaudi infections of mice, using a Bayesian
statistical framework. The accuracy of different models in
explaining the RBC and parasite densities was quantified.
We identify the role of different types of immune-
mediated mechanism, and show that RBC production
(erythropoiesis) increases during infection. Differences
between mouse phenotypes are explained. Our study
highlights the informative power of model-fitting techni-
ques in explaining biological systems.
Immune and Red Blood Cell Responses to Malaria
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The averaged dynamics of each treatment are shown in Fig. 1.
The AJ clone (solid line) does not show the normal higher peak
density compared to the AS clone (dotted line); however, the AJ
clone exhibits a higher density during the exponential growth phase
compared to AS. Parasite density tends to level off in reconstituted
and nude mice from day 12, but continues declining in the wildtype,
presumably because of a stronger immune response in these mice.
In reconstituted and wildtype mice, the AJ clone causes greater
anaemia than the AS clone. All three mouse phenotypes show an
earlier drop in RBC density from days 6–8 when infected with AJ
compared to AS. The recovery of RBC density in nude mice is
weaker than in reconstituted and wildtype mice. We discuss these
observations below in relation to inferences from the model fitting.
The mathematical model
In Plasmodium chabaudi, pRBCs rupture synchronously every
24 hours, releasing on average 6–8 parasites (merozoites) into the
bloodstream [40]. These newly released merozoites infect further
RBCs and the cycle repeats. The rupture of pRBCS (schizogony)
occurs at approximately midnight under normal lighting condi-
tions [41].
We use a discrete-time formulation to model the dynamics,
where each time step corresponds to a single day. The start of day
i is defined as the point immediately following rupture of pRBCs,
before any infection has occurred (i.e., the point at which
merozoites are released into the bloodstream). The densities of
merozoites and uRBCs at the start of day i are denoted Mi and Ni,
respectively. We assume that the processes determining RBC
density occur on two non-overlapping timescales. The first
corresponds to the short infection phase during which merozoites
infect RBCs, which occurs within a few minutes following
schizogony. The second and subsequent timescale (the remainder
of the day) corresponds to the RBC turnover phase: here the
parasites replicate within pRBCs, new uRBCs are released into the
bloodstream and, if active, the (non-merozoite) immune responses
clear pRBCs and uRBCs. At the end of the RBC turnover phase,
surviving pRBCs rupture and release new merozoites.
The infection phase. The infection dynamics at the start of
day i are modelled in continuous time t, using a formulation based
on [14]. Let M(t), U(t), P1(t) and P2(t) denote, respectively, the
densities of merozoites, uRBCs, pRBCs containing a single parasite,
and pRBCs containing multiple parasites. The variables’ depend-
ence on i is dropped for clarity. The dynamics are then described by
the following system of differential equations:
dM(t)
dt
~{bM(t)(U(t)zP1(t)zP2(t)){(mzIm,i)M(t) ð1Þ
dU(t)
dt
~{bM(t)U(t) ð2Þ
dP1(t)
dt
~bM(t)U(t){bM(t)P1(t) ð3Þ
dP2(t)
dt
~bM(t)P1(t) ð4Þ
Here b is the rate at which merozoites infect RBCs. The constant m
gives the decay rate of merozoites due to natural mortality and loss
from the circulation. The function Im,i is the immune-mediated
clearance rate of merozoites on day i, which is assumed constant
over the short infection phase. Time t has units of seconds, reflecting
the rapid infection of RBCs.
The initial densities are defined as: M(0)~Mi, U(0)~Ni and
P1(0)~P2(0)~0. The total number of RBCs, Ni~U(t)z
P1(t)zP2(t), remains constant over this timespan. An explicit solution
to equation (1) is obtained by integrating with respect to M(t), i.e.,
M(t)~Mi exp({(bNizmzIm,i)t) ð5Þ
As noted above, infection occurs over a relatively short
timescale compared to the other processes determining the RBC
densities. We therefore assume that the densities at the end of the
infection phase are given in the limit as t??. In this limit, the
density of merozoites tends to zero (M(?)~0).
In allowing for the possibility of multiple infections, we
introduce two further variables. Let p1(t) and p2(t) denote the
total densities of parasites (merozoites) within singly-parasitised
and multiply-parasitised RBCs, respectively. Note that, by
definition, P1(t)~p1(t) and P2(t)vp2(t).
Figure 1. Parasite and RBC dynamics. Data on parasite density and
RBC density, averaged across mice from individual treatments
(mean+1 S:E:).
doi:10.1371/journal.pcbi.1000946.g001
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The RBC and parasite densities following infection can now be
derived. Once released into the bloodstream, a given merozoite will
either infect a RBC or be removed from the circulation (due to
natural decay or the activity of the merozoite-targeting immune
response). These processes occur at rates bNi, m, and Im,i,
respectively. A given merozoite therefore has probability bNi=
(bNizmzIm,i) of infecting a RBC. Multiplying this probability by
the initial density of merozoites, and dividing by the total RBC
density, gives the average number of parasites per RBC (l):
l~
Mi
Nizm^zI^m,i
ð6Þ
The substitutions m^~m=b and I^m,i~Im,i=b are made because b
and m are non-identifiable (i.e., we cannot estimate their values
separately).
Since infections occur independently, the probability of a given
RBC being infected by k merozoites is Poisson-distributed with
parameter l, i.e., Pr(k infections; l)~lke{l=(k!). The uRBC,
pRBC and parasite densities at the end of the infection phase are
therefore:
U(?)~Ni exp({l) ð7Þ
P1(?)~p1(?)~Nil exp({l) ð8Þ
P2(?)~Ni(1{(1zl)exp({l)) ð9Þ
p2(?)~Nil(1{exp({l)) ð10Þ
The density of parasites within multiply-parasitised RBCs is
obtained by noting that the total parasite density equals Nil.
The RBC turnover phase. The RBC turnover dynamics
occur after the infection dynamics on each day i. They are
modelled in continuous time s, which has units of days. Let U(s),
P1(s) and P2(s) denote, respectively, the densities of uRBCs,
singly-parasitised RBCs and multiply-parasitised RBCs on this
timescale. Similarly, let p1(s) and p2(s) denote, respectively, the
densities of parasites within singly-parasitised and multiply-
parasitised RBCs. Again, we drop the dependence on i for clarity.
In the absence of infection, RBCs are lost through natural
mortality and gained through the production of new cells
(erythropoiesis). We take RBC decay as d~0:025day{1 [42,43].
This implies that the baseline erythropoiesis rate, needed to
replenish the lost RBCs, is dK , where K is the normal RBC density.
Erythropoiesis may be upregulated in response to the anaemia
caused by the infection. We assume that erythropoiesis upregulates
d days after initial innoculation. The level of upregulation on day i
is linearly proportional to the difference between the normal RBC
density, K , and the RBC density t days earlier, Ni{t. The
parameter t measures the lag in feedback between RBC density
and the level of erythropoiesis. The upregulation of erythropoiesis
is then given by h(K{Ni{t), where h gives the proportion of the
RBC deficit that is recovered.
We assume that multiply-parasitised RBCs have an additional
mortality rate, d2. This allows for the possibility that individual
RBCs infected with more than one parasite may be exploited to
such an extent that the cell dies before the parasite is able to
reproduce (i.e., prior to schizogony). The increased mortality rate
could conceivably vary between 0 and ? as we have no prior
evidence to constrain it. We therefore re-parameterise using
d2~a=(1{a), with a prior on a of Uniform(0, 1).
The immune-mediated clearance rates of pRBCs and uRBCs on
day i are given by the functions Iu,i and Ip,i respectively. As such, we
assume that they change from one day to the next, but remain
constant within a single day. This, and the relationship between
erythropoiesis and Ni{t, are simplifying assumptions that allow us
to derive analytical solutions to our equations. Using continuous-
time functions would require numerical solutions of delay
differential equations which would be computationally prohibitive.
A consequence of these assumptions is that immune and
erythropoietic rate parameter estimates may be biased. This is of
no practical significance in our analysis because we are interested in
relative differences in immune and erythropoietic responses across
experimental treatments, rather than absolute values.
Given the above assumptions, the dynamics of the RBC
turnover phase are described by the following system of differential
equations:
dU(s)
ds
~dK{(dzIu,i)U(s)z
0 if iƒd
h(K{Ni{t) if iwd

ð11Þ
dP1(s)
ds
~{(dzIp,i)P1(s) ð12Þ
dP2(s)
ds
~{(dzIp,izd2)P2(s) ð13Þ
p1(s)~P1(s) ð14Þ
dp2(s)
ds
~{(dzIp,izd2)p2(s) ð15Þ
The solution of this system of equations is derived in the
Supporting Information (Text S1).
Rupture of pRBCs. The final event on day i is the rupture of
pRBCs and release of merozoites. At this point each surviving parasite
produces v merozoites and the pRBC density returns to zero. The
uRBC density on the (iz1)th day is equal to U(1), given as:
Niz1~Ni exp({(lzdzIu,i))z
1{exp({(dzIu,i))
dzIu,i
|
dK if iƒd
h(K{Ni{t)zdK if iwd
( ð16Þ
The merozoite density on the (iz1)th day is equal to
v(p1(1)zp2(1)):
Miz1~vNil(exp({(lzdzIp,i))
z(1{exp({l))exp({(dzd2zIp,i)))
ð17Þ
Equations (16)–(17) define the model for updating the uRBC
and merozoite densities immediately following rupture. At this
Immune and Red Blood Cell Responses to Malaria
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time (about 00:00 hrs) the parasite density is equal to the merozoite
density. In the experiment, however, RBC and parasite densities
were measured at approximately 08:00 hrs, roughly
1
3
of the time
between successive rupture events. We therefore fit the model
predictions for RBC and parasite densities during the RBC
turnover phase at the point when s~
1
3
.
The mice were innoculated intraperitoneally with 105 singly-
parasitised RBCs at 08:00 hrs on day 0. Although all mice received
this same initial dose, we considered that not all of the pRBCs
might enter the bloodstream; we therefore fit the initial density of
pRBCs, P0, to the data. The initial RBC density was assumed to
be the normal RBC concentration, K . The full list of variables,
functions and parameters is given in Table 1.
Immune-mediated clearance rates. We model the immune
response as three distinct components that clear merozoites, pRBCs
and uRBCs, respectively. On a given day i, the functions I^m,i, Ip,i and
Iu,i give the immune-mediated clearance rates of merozoites, pRBCs
Table 1. Variables, functions and parameters used in the models.
Independent variables
t time second
s time day
Dependent variables
M(:) density of merozoites parasites=ml
U(:) density of uRBCs cells=ml
P1(:) density of singly-parasitised RBCs cells=ml
P2(:) density of multiply-parasitised RBCs cells=ml
p1(:) parasite density (singly-parasitised RBCs) parasites=ml
p2(:) parasite density (multiply-parasitised RBCs) parasites=ml
Ni total RBC density on day i cells=ml
Functions
Im,i immune-mediated clearance rate of merozoites on day i second{1
Ip,i immune-mediated clearance rate of pRBCs on day i day{1
Iu,i immune-mediated clearance rate of uRBCs on day i day{1
I^m,i Im,i=b cells=ml
Parameters
v burst size parasites
h rate of upregulation of erythropoiesis day{1
d time delay before upregulation day
t time lag in erythropoiesis day
K normal RBC density cells=ml
P0 initial parasite density parasites=ml
d natural death rate of RBCs day{1
d2 increased death rate of multiply-parasitised RBCs day{1
b infection rate (cells=ml){1second{1
m natural loss rate of merozoites second{1
m^ m=b cells=ml
cm maximum level of merozoite-targeting immunity cells=ml
cp maximum clearance rate of pRBC-targeting immunity day{1
cu maximum clearance rate of uRBC-targeting immunity day{1
sm start day of merozoite-targeting immunity day
sp start day of pRBC-targeting immunity day
su start day of uRBC-targeting immunity day
rm rise time of merozoite-targeting immunity day
rp rise time of pRBC-targeting immunity day
ru rise time of uRBC-targeting immunity day
dm duration of merozoite-targeting immunity day
dp duration of pRBC-targeting immunity day
du duration of uRBC-targeting immunity day
doi:10.1371/journal.pcbi.1000946.t001
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and uRBCs, respectively. The merozoite targeting response operates
during the infection phase, while the pRBC and uRBC targeting
responses operate during the RBC turnover phase.
An immune component is defined in terms of four parameters:
the day of initial activation (sm, sp, su), the maximum clearance
rate (cm, cp, cu), the time (measured in days) taken to reach
maximum clearance rate (rm, rp, ru), and the duration in days of
the immune response (dm, dp, du). Initially, the clearance rates of
all three immune responses are set to zero. When an immune
response is activated, the clearance rate increases to its maximum
level over a number of days. Once the given duration has elapsed,
as measured from the start day, the clearance rate returns to zero.
The expressions for the three immune responses are
I^m,i~
0 if ivsm
cm(i{sm)=rm if smƒivsmzrm
cm if smzrmƒivsmzdm
0 if smzdmƒi
8>><
>>:
ð18Þ
Ip,i~
0 if ivsp
cp(i{sp)=rp if spƒivspzrp
cp if spzrpƒivspzdp
0 if spzdpƒi
8>><
>>:
ð19Þ
Iu,i~
0 if ivsu
cu(i{su)=ru if suƒivsuzru
cu if suzruƒivsuzdu
0 if suzduƒi
8>><
>>:
ð20Þ
Tested hypotheses
Using the statistical algorithm described in the Supporting
Information (Text S1, Figure S1 and Figure S2), we fit to the
observed data on RBC and parasite densities. The fitted
parameters are given in Table 2, along with their prior
distributions. The prior distributions were based either on values
taken from the literature, or approximate estimates obtained
before the main model-fitting (see Text S1 for details).
Our aim is to find a set of minimal adequate models which
explain the data well and contain as few parameters as possible.
We take as our baseline the model described above. This is
denoted P0 and contains 20 fitted parameters. We developed a set
of nested and non-nested models in which specific assumptions are
made about the immune and erythropoietic responses (outlined in
Table 3). All models were fitted to the data. Each model fit was
then evaluated relative to that of the baseline. The model fits were
compared using Bayes’ factors, which naturally penalise overfitting
[44] (refer to Text S1 for further details on measurement error, the
likelihood function, model fitting, assessment and comparison).
We estimate parameters separately for each mouse, rather than
across treatments. Even inbred mice are phenotypically different,
and these differences result in variability in parasite and RBC
dynamics. Immune responses are significant sources of variability
in vivo; but we might also expect variation between mice in
parameters such as infection rate, because of the multifactorial
nature of such processes which involve the interaction of many
host and parasite proteins. We therefore make no assumption
about which parameters are invariant across mice and instead
estimate parameters separately for each mouse. This method
allows us to infer parameter (and hence process) variability within
and between treatments from the posterior estimates.
Removal of immune components. We investigated
removing individual components of the immune response (i.e.,
the merozoite, pRBC or uRBC targeting components). The
remaining two components were assumed to function as normal.
Synchronisation of immune components. This involved
setting the same start, rise and duration times for different immune
components. Thus, synchronisation of the pRBC and uRBC
targeting arms corresponded to sp~su, rp~ru and dp~du. Note
that the synchronised components generally have different
maximum levels (cp=cu).
Control of peak parasite density. All three immune
components are included in the model and function independently.
However, the start time of a given component is restricted to occur
after the initial peak of parasite density: the earliest this immune
component can activate is day 8 post-innoculation. The number of
parameters is the same as in the baseline model, but a restriction is
placed on the prior for immune start time.
Upregulation of erythropoiesis. We considered omitting
the upregulated erythropoietic response. In this case the parameter
h is set to zero, which implies d and t are unnecessary (see
equation (11)). We also separately investigated the effect of
omitting the delay, or the lag in feedback time, or both.
Mortality of multiply-parasitised RBCs. In the baseline
model, multiply-parasitised RBCs have a higher mortality rate
than singly-parasitised RBCs. We examined a model where
multiply-parasitised and singly-parasitised RBCs have the same
mortality rate (i.e., setting the increased mortality rate, d2, to zero).
Number of merozoites produced per multiply-parasitised
RBC. In the baseline model, multiply-parasitised RBCs produce
merozoites relative to the number of parasites that infect them
(each parasite produces v merozoites upon schizogony). However,
it is possible that there is some constraint on the number of
merozoites due to host resources. We therefore examined a model
where each multiply-parasitised RBC produces only v merozoites,
i.e., Miz1~v(P1(1)zP2(1)).
Table 2. Parameters and their prior distributions.
Parameter Prior distribution Source
v NT(7,0:25) [40]
h NT(0:3,0:01) [8,14]
d U(0, 12) [30]
t U(0, 6) [14,58]
K NT(1:06|10
7,1012)
log10 (P0) NT(1:5,0:25)
d 0.025 [42,43]
a~
d2
1zd2
U(0, 1)
m^ U(0,2|107)
cm NT(10
8,1016)
cp , cu NT(1,1)
sm , sp , su U(0, 19)
dm , dp , du U(0, 19)
rm , rp , ru U(0, 19)
NT is a normal distribution truncated at 0.
doi:10.1371/journal.pcbi.1000946.t002
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Results
Assessment of the baseline model
We begin by analysing the baseline model, P0. The fits to all
mice are shown in Figs. 2–4. Note that the posterior predictive
interval (PPI) of the dynamics widens from around day 15 for some
mice because of the lack of data.
The model fits appear to adequately explain the data. A more
rigorous assessment of the model fits is attained by plotting the
overlaid standardised residuals for parasite and RBC densities.
Fig. 5 shows the standardised residuals (the blue crosses) for all
mice across the six treatments. Poor fits are suggested by outlying
and serially correlated residuals.
The fits to parasite density are accurate but not perfect. There
are no outliers, but the model tends to overestimate parasite
density on day 4. This is unexpected because we expect parasite
density to be growing exponentially during this time, and indeed
this is how the model behaves. This discrepancy suggests that
parasite density may initially grow at a slower than exponential
rate. Also, the model tends to underestimate parasite density on
day 11. Currently, we have no explanation for this. The fits to
RBC density are accurate, except on day 8 where RBC density is
marginally overestimated. Therefore, the model may not be
correctly capturing the trough in RBC density.
Analysis of hypotheses
We calculated the Bayes’ factors of models Pj , for
j~1, . . . , 15, relative to the baseline model P0. We adopt the
scale of interpretation for Bayes’ factors proposed by Jeffreys [45]
and reproduced in Table 4. For ease of interpretation, the Bayes’
factors are converted to deciBans; i.e., dB~10 log(Bayes’ factor).
Bayes’ factors were calculated for each mouse, giving a total of 38
values for each model comparison. The full list of Bayes’ factors is
given in Table S1 and Table S2. For conciseness and clarity, we
report for each model: (i) the sum of the deciBans for all mice
within each treatment, and (ii) the sum of the deciBans for all mice
across treatments (Table 5). We also report the standard error of
the deciBans. Errors occur because deciBans are estimated from a
finite sample of the posterior distribution. Our inferences are
conservative; thus, we interpret a deciBan of 5:3+4:9 as ‘‘barely
worth mentioning’’ (see Table 4).
Statistical comparison of parameter values between treatments
was performed using Analysis of Variance (ANOVA) in the R
statistical package [46]. The method was as follows. For a given
parameter, we first took the mean of the posterior distribution, E(:),
for each individual mouse. The mean for a given treatment,
E(:)treatment, was then calculated as the average of the posterior
mean values taken across all mice in the treatment.
Removal of immune components. We tested which of the
immune components are necessary to explain our data. There is
substantial to decisive evidence for immune-mediated clearance of
pRBCs (Table 5, P2). The evidence is weakest in AS-infected
reconstituted mice (dB~11:6+5:4) and AS-infected nude mice
(dB~16:0+5:8), and strongest in wildtype mice (AJ:
dB~73:8+ 8:7, AS: dB~67:4+ 8:6). This may simply reflect
the shorter time series in the reconstituted and nude mice, or
alternatively, may indicate a stronger immune response in the
wildtype. Overall, the evidence for pRBC clearance is decisive
(dB~246:8+ 18:5).
We then considered the evidence for immune-mediated
clearance of uRBCs (Table 5, P3). In all treatments except the
AJ-infected nude mice, there is very strong to decisive evidence for
this mechanism. The most evidence is in wildtype mice (AJ:
dB~291:2+ 8:7, AS: dB~345:8+ 8:6). Overall, the evidence
for uRBC clearance is decisive (dB~795:8+ 18:5).
Next, we considered the evidence for immune-mediated
clearance of merozoites (P1, Table 5). There is no evidence in
nude mice (AJ: dB~3:3+ 8:2, AS: dB~5:9+ 5:8), or AJ-
infected reconstituted mice (dB~10:6+ 8:0). However, there is
substantial evidence in wildtype mice (AJ: dB~15:6+ 8:7, AS:
dB~18:2+ 8:6), and very strong evidence in AS-infected
reconstituted mice (dB~20:7+ 5:4). Overall, the evidence for
this immune mechanism is decisive (dB~74:3+ 18:5). It is
notable that the Bayes’ factors for immune-mediated merozoite
clearance are, on the whole, much lower than those for pRBC
clearance and uRBC clearance. This suggests that, although
immune-mediated merozoite clearance definitely occurs, its effect
on the RBC and parasite dynamics is relatively weak compared to
that of the other immune components.
The 95% PPIs of the immune-mediated uRBC and pRBC
clearance rates are shown in Figs. 6 and 7. For the wildtype mice
(for which we have the most data), the PPIs of the uRBC clearance
rates do not contain zero (Fig. 6). By contrast, in all of the nude
and most of the reconstituted mice, the 95% PPIs of the uRBC
clearance rates always contain zero. This shows the crucial
importance of uRBC clearance in the wildtype mice, as reflected
in the very high Bayes’ factors (P3, Table 5). The 95% PPIs of the
pRBC clearance rates contain zero for all except one of the mice
(Fig. 7). We believe this is due to the fact that merozoite clearance,
by directly targeting the parasite, is able to compensate for the
absence of this mechanism.
Wildtype mice were found to have lower maximum uRBC
clearance rates than reconstituted mice (E(cu)wild~0:49 day
{1,
E(cu)recon~1:13 day
{1, F1,22~42:0, p~2|10
{6). In turn, the
reconstituted mice have lower maximum uRBC clearance rates
Table 3. Description of tested models.
Model Description parameters affected
P0 baseline model
P1 no merozoite clearance cm~0
P2 no pRBC clearance cp~0
P3 no uRBC clearance cu~0
P4 synchronised pRBC
and uRBC clearance
sp~su , dp~du , rp~ru
P5 synchronised merozoite and uRBC
clearance
sm~su , dm~du , rm~ru
P6 synchronised merozoite and pRBC
clearance
sm~sp , dm~dp , rm~rp
P7 pRBC clearance after peak
parasite density
sp*U(8,19)
P8 uRBC clearance after peak
parasite density
su*U(8,19)
P9 merozoite clearance after
peak parasite density
su*U(8,19)
P10 no RBC upregulation h~0
P11 no delay in upregulation
of erythropoiesis
d~0
P12 no time lag in erythropoieses t~0
P13 no delay or time lag in erythropoiesis d~t~0
P14 no loss of multiply-parasitised RBCs d2~0
P15 multiply-parasitised RBCs produce
only v merozoites
doi:10.1371/journal.pcbi.1000946.t003
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Figure 2. Model fits. Fits of baseline model P0 to parasite density and RBC density for reconstituted mice infected with the AJ strain (top panels), or
the AS strain (bottom panels). Crosses are data. Light-grey regions correspond to 95% posterior predictive intervals (PPI); dark-grey regions
correspond to 50% PPIs. The solid lines give the best-fit (posterior mode) solutions.
doi:10.1371/journal.pcbi.1000946.g002
Figure 3. Model fits. Fits of baseline model P0 to parasite density and RBC density for nude mice infected with the AJ strain (top panels), or the AS
strain (bottom panels). Crosses are data. Light-grey regions correspond to 95% posterior predictive intervals (PPI); dark-grey regions correspond to
50% PPIs. The solid lines give the best-fit (posterior mode) solutions.
doi:10.1371/journal.pcbi.1000946.g003
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than nude mice (E(cu)nude~1:32 day
{1, F1,24~4:88, p~0:04).
These results suggest that the higher immunocompetence of
wildtype mice (and to a lesser degree, reconstituted mice) is
associated with weaker clearance of uRBCs.
Synchronisation of immune components. We considered
whether the pRBC and uRBC immune components could be
synchronised, thus reflecting a common effector mechanism (P4,
Table 5). There is substantial evidence against synchronisation in
wildtype mice (AJ: dB~16:1+ 8:7, AS: dB~16:1+ 8:6). The
other treatment groups provide no significant evidence either for or
against synchronisation. Overall, there is strong evidence that the
uRBC and pRBC targeting components are not synchronous
(dB~29:5+ 18:5). However, the evidence against synchronisation
of merozoite and uRBC clearance, or synchronisation of merozoite
and pRBC clearance is decisive (P5 andP6, Table 5). This suggests
that, although they are not synchronous, the temporal patterns of
pRBC and uRBC clearance in P. chabaudi are closer to each other
than to the temporal pattern of merozoite clearance.
Control of peak parasite density. We investigated if the
immune-mediated responses targeting merozoites, pRBCs and
uRBCs are associated with control of the initial peak of parasite
density. We restricted the immune responses to occur only after
the initial peak. Since the peak occurs on days 7–9 post-
innoculation, the priors on sm, sp and su were therefore
restricted to Uniform(8, 19). Thus, the initial clearance could
not begin until day 9 at the earliest.
Across the treatments, there is substantial to decisive evidence
that pRBC clearance is associated with control of the peak of
parasite density (P7, Table 5). This hypothesis is supported in all
three phenotypes (wildtype, reconstituted, nude). The evidence
that uRBC clearance is associated with control of the initial peak
differs greatly across the treatments (P8, Table 5): there is decisive
evidence in wildtype mice, and strong evidence in AS-infected
nude mice, but no evidence in reconstituted mice or AJ-infected
nude mice. There is very strong evidence that merozoite clearance
is associated with control of the peak in AS-infected reconstituted
mice, but no evidence in any of the other treatments (P9, Table 5).
Upregulation of erythropoiesis. We investigated if
erythropoiesis is upregulated above its baseline level in response to
anaemia, and if so, the form of this upregulation. There is decisive
evidence for upregulation of erythropoiesis across all treatments (P10,
Table 5). The marginal posterior distributions for the level of
upregulation, h, are shown in Fig. 8. The level of upregulation
is significantly different in nude mice compared to wildtype
and reconstituted mice (E(h)wild,recon~0:32 day
{1, E(h)nude~
0:24 day{1, F1,36~13:4, p~10
{3).
In five of the six treatments there is no evidence for a delay prior
to upregulation (P11, Table 5). The exception is in AS-infected
wildtype mice, which give strong evidence for a delay
(dB~21:7+ 8:6). The marginal posterior distributions of d
indicate a delay of around 9 days in these mice (Fig. 8).
The AJ-infected reconstituted mice provide strong evidence for a
time lag in the feedback between RBC density and the erythropoietic
response (P12, dB~18:1+ 8:0, Table 5). There is no evidence for a
time lag in any of the other treatments; in fact, including a time lag
causes overfitting of the model in the nude and AS-infected wildtype
treatments (indicated by the negative deciBan values).
We also investigated a model which omitted both the time delay
before upregulation, and the lag in feedback in the erythropoietic
response (P13, Table 5). The strongly negative deciBans for the
nude treatments suggest overfitting in these mice. The evidence in
wildtype and AJ-infected reconstituted mice is strong to decisive
for at least one process (i.e., it suggests either a delay before
upregulation, or a lag in feedback time).
Figure 4. Model fits. Fits of baseline model P0 to parasite density and RBC density for wildtype mice infected with the AJ strain (top panels), or the
AS strain (bottom panels). Crosses are data. Light-grey regions correspond to 95% posterior predictive intervals (PPI); dark-grey regions correspond to
50% PPIs. The solid lines give the best-fit (posterior mode) solutions.
doi:10.1371/journal.pcbi.1000946.g004
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Mortality of multiply-parasitised RBCs. We investigated
whether multiply-parasitised RBCs are killed before schizogony
occurs (P14, Table 5). Overall, there is decisive evidence that
multiply-parasitised cells experience a higher mortality rate
(dB~221:3+ 18:5). The fitted value of d2, averaged across all
mice (Fig. 8), is 100:42~2:6 day{1, which translates into a half-life
of about 6.4 hrs. However, the marginal posteriors vary from
0:01 to 100 day{1, so the data do not allow us to estimate a
precise value.
Number of merozoites produced per multiply-parasitised
RBC. We investigated whether, in multiply-parasitised RBCs
that survive to schizogony, each parasite produces v merozoites,
or whether only a single parasite survives to produce v merozoites
(P15, Table 5). In terms of the Bayes’ factors, there is no evidence
to distinguish between these two hypotheses (dB~{6:4+ 18:5).
This may be due to the higher mortality rate of multiply-
parasitised RBCs. According to this explanation, because only a
few of the multiply-parasitised cells survive to reproduce, the
overall effect of these cells producing a higher number of parasites
is negligible. In this case, we cannot draw a conclusion either way.
Other inferences
Difference between the AS and AJ clones. The AJ strain is
known to be a more virulent clone than AS. We explored the
potential reasons for this. There was no difference between the
clones in terms of the maximum immune-mediated pRBC
clearance rate (F1,32~0:92, p~0:34), or the maximum immune-
mediated uRBC clearance rate (F1,34~2:47, p~0:13). Neither
was there a difference in the additional mortality rate of multiply-
parasitised cells (F1,36~0:41, p~0:53). The posterior means of the
transmission parameter, m^, also did not differ between the clones
(F1,34~3:3, p~0:08).
Interestingly, the initial parasite density was found to be higher
in the AJ clone compared to AS (E(P0)AJ~36 parasites=ml,
E(P0)AS~20 parasites=ml, F1,36~12:9, p~10
{3; Fig. 8). Although
the infective dose was the same for all mice, a higher initial density for
the AJ clone could have arisen through experimental error;
alternatively, it could be due to the AJ clone being better at entering
the bloodstream from the peritoneum. Either hypothesis could explain
the higher AJ densities during the exponential growth phase, and why
the AJ clone causes an earlier drop in RBC density (Fig. 1).
Table 4. Scale of interpretation of Bayes’ factors.
dB Evidence against model Pj
v0 Negative (supports Pj )
0 to 5 Barely worth mentioning
5 to 10 Substantial
10 to 15 Strong
15 to 20 Very strong
w20 Decisive
Values are in deciBans (dB).
doi:10.1371/journal.pcbi.1000946.t004
Figure 5. Standardised residuals. Assessment of baseline model fits to all mouse data by standardised residuals. Top panel: parasite density,
bottom panel: RBC density. Each cross represents the standardised residual of a time point for an individual mouse. These have an approximately
normal distribution with mean 0 and variance 1. The solid red line joins the means of the standardised residuals at each time point. The dashed lines
delimit the 95% predictive interval for the expected mean standardised residual for the same number of residuals as the data, Bonferroni corrected
for the number of time points (see Text S1 for details). The model systematically overestimates the data when the red line lies below the 95%
predictive interval, and underestimates the data when it lies above this interval. The y-axis is scaled in units of standard deviations.
doi:10.1371/journal.pcbi.1000946.g005
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Difference between the phenotypes. If we consider the
marginal posterior distributions for burst size, v, it is clear that
these do not differ from the prior distribution of Normal(7, 1)
across any of the mice (Fig. 8). This implies that the data contain
no more information about burst size than our prior knowledge.
We observed a difference between the phenotypes in the
transmission parameter, m^. The mean value of this parameter was
significantly higher in wildtype and reconstituted mice compared to
nude mice (E(m^)wild,recon~4:6|10
6cells=ml, E(m^)nude~2:8|
106cells=ml, F1,36~12:1, p~10
{3). As m^~m=b, this suggests that
either the background mortality rate of merozoites is higher, or that the
RBC infection rate is lower, in wildtype and reconstituted mice than in
nude mice.
RBC dynamics after the peak of parasite density. After
day 12, the 95% PPIs of the dynamics show that parasite densities
can increase or decrease (Figs. 2–4). This is due to a lack of data
describing parasite density, and implies that infection has a
marginal or negligible effect on the RBC dynamics at this stage.
We predict that immune-mediated uRBC clearance is the major
determinant of RBC dynamics over days 12–18. This can be seen
by comparing the RBC dynamics (Figs. 2–4) and the predicted
uRBC clearance rates (Fig. 7). The correlations are particularly
clear in wildtype (AS and AJ) and reconstituted (AJ) mice. Whether
RBC density rises, plateaus or declines after day 12, depends on
whether the uRBC clearance rate drops to zero, plateaus or rises,
respectively.
Discussion
The aim of this paper was to provide a quantitative assessment
of the immune and erythropoietic responses in Plasmodium chabaudi
infections. Hypotheses were drawn from experimental data and
the mathematical modelling literature. These were fit to data on
malaria infected mice using a Bayesian statistical framework.
Crucially, by quantifying the experimental error, we were able to
provide a rigorous assessment of the model fit. In particular, we
were able to evaluate and compare the accuracy of different
models in explaining the data. Models were compared using
Bayes’ factors, which impose a penalty for additional parameters.
We interpreted our results with reference to the product of Bayes’
factors (sum of deciBans) within and across treatments.
Our results provide very strong evidence that the immune
response to P. chabaudi involves clearance of both parasitised and
unparasitised RBCs. Both effects were evident during the initial
peak of parasite density, implying that control of the peak is
regulated by the immune response. Previous modelling studies
have suggested that innate or early specific immune responses
regulate the initial dynamics of parasite density and anaemia
[8,9,21,47]. Our study provides a statistically rigorous analysis in
support of this hypothesis. Parasite-infected erythrocyte surface
antigens (PIESA) may be an important immune target in both
rodent and human malarias. In the case of P. falciparum, a
longitudinal study of Kenyan children found that clinical malaria
Table 5. Comparison of each model to the baseline model P0 using Bayes’ factors.
Model
Treatment P1 P2 P3 P4 P5
Reconstituted AJ 10:6+8:0 24:6+8:0 94:3+ 8:0 2:9+8:0 10:9+8:0
Reconstituted AS 20:7+5:4 11:6+5:4 21:7+5:4 {3:6+5:4 {9:3+5:4
Nude AJ 3:3+8:2 53:4+8:2 6:9+8:2 8:4+8:2 {14:4+8:2
Nude AS 5:9+5:8 16:0+5:8 36:1+5:8 {10:5+5:8 {23:4+5:8
Wildtype AJ 15:6+8:7 73:8+8:7 291:2+8:7 16:1+8:7 46:8+8:7
Wildtype AS 18:2+8:6 67:4+8:6 345:8+8:6 16:1+8:6 60:9+8:6
All 74:3+18:5 246:8+18:5 795:8+18:5 29:5+18:5 71:5+18:5
P6 P7 P8 P9 P10
Reconstituted AJ 35:6+8:0 17:2+8:0 {0:6+8:0 3:3+8:0 3350:5+8:0
Reconstituted AS 46:4+5:4 13:3+5:4 {1:0+5:4 21:5+5:4 1493:3+5:4
Nude AJ 74:3+8:2 37:9+8:2 {0:6+8:2 2:6+8:2 837:2+8:2
Nude AS 51:4+5:8 12:6+5:8 18:5+5:8 9:7+5:8 92:4+5:8
Wildtype AJ 39:5+8:7 39:2+8:7 123:8+8:7 {4:7+8:7 2123:3+8:7
Wildtype AS 15:7+8:6 34:4+8:6 170:8+8:6 5:1+8:6 1229:8+8:6
All 262:9+18:5 154:4+18:5 310:9+18:5 38:3+18:5 9126:4+18:5
P11 P12 P13 P14 P15
Reconstituted AJ {6:0+8:0 18:1+8:0 43:6+8:0 37:7+8:0 1:4+8:0
Reconstituted AS {1:4+5:4 0:4+5:4 8:2+5:4 46:9+5:4 {6:5+5:4
Nude AJ {2:1+8:2 {14:6+8:2 {21:3+8:2 44:5+8:2 {0:3+8:2
Nude AS {6:7+5:8 {21:6+5:8 {26:5+5:8 39:4+5:8 {5:3+5:8
Wildtype AJ 1:8+8:7 {4:9+8:7 24:9+8:7 31:8+8:7 6:0+8:7
Wildtype AS 21:7+8:6 {21:5+8:6 43:5+8:6 21:0+8:6 {1:7+8:6
All 7:4+18:5 {44:0+18:5 72:5+18:5 221:3+18:5 {6:4+18:5
Values are deciBans+2 standard errors of the deciBans for each treatment and all treatments.
doi:10.1371/journal.pcbi.1000946.t005
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was caused by parasite isolates expressing PIESA variants that
corresponded to gaps in the repertoire of antibodies carried by the
children before they became ill [48].
We have shown that uRBC clearance by the immune system
plays a key role in determining the infection dynamics of P.
chabaudi. Experimental studies confirm that in the rodent malaria
Figure 6. Predicted uRBC clearance rates. Posterior predictive intervals of immune-mediated uRBC clearance rates for the baseline model. Light-
grey regions correspond to 95% PPIs; dark grey regions correspond to 50% PPIs. The solid lines give the best-fit (posterior mode) solutions. Note the
different scales for reconstituted, nude and wildtype mice.
doi:10.1371/journal.pcbi.1000946.g006
Figure 7. Predicted pRBC clearance rates. Posterior predictive intervals of immune-mediated pRBC clearance rates for the baseline model. Light-
grey regions correspond to 95% PPIs; dark grey regions correspond to 50% PPIs. The solid lines give the best-fit (posterior mode) solutions.
doi:10.1371/journal.pcbi.1000946.g007
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P. berghei [10], and also in P. falciparum which infects humans [11],
the vast majority of anaemia is due to uRBC loss. Our results
suggest that the level of anaemia following control of the initial
peak (from about day 12), is mediated by the activity of the uRBC
targeting response. This provides a mechanistic explanation for
the variation in RBC dynamics between individual mice. If uRBC
clearance decreases following control of the initial peak, then the
increase in erythropoiesis that occurs from approximately day 10
allows the host to recover quickly from anaemia; in contrast,
prolonged uRBC clearance is associated with a slow recovery from
anaemia. Due to the lack of data to describe parasite density, the
role of the pRBC targeting response during this later stage of
infection is less certain. Our results suggest that the immune
responses targeting pRBCs and uRBCs do not show a high degree
of synchronisation. This implies they may be controlled by
different effector mechanisms.
Our model does not account for the antigenic variation that
occurs in P. chabaudi infections [49,50]. Indeed, our model
formulation only permits a single ‘‘switching-on’’ and ‘‘switch-
ing-off’’ of each immune component (merozoite, pRBC, uRBC),
and therefore does not distinguish between non-specific (innate)
versus specific antibody responses to antigenically distinct variants.
We modelled the infection up until day 18, at which point
antigenic variation may have a significant effect on the dynamics.
In some mice, the data show a second drop in RBC density
following the recovery from initial anaemia (Fig. 2). Although we
only have data on parasite density up to day 14, this second
anaemia is commensurate with a recrudescent parasite density.
However, it is significant that our model is able to explain the
observed dynamics so well without including antigenic variation
(Fig. 5). Extending the model up to, for example, day 30 post-
infection would require explicit modelling of immune responses to
the different antigenic variants. Such modelling would probably
need to include both short-lived (innate) and long-lasting antibody
responses, and may also need to consider cross-reactivity. The
cascade of sequentially dominant antigenic variants seen in P.
falciparum infections has recently been explained as the result of
short-lived cross-reactive immune responses directed against
shared epitopes [36].
Our results are consistent with the observation that T-cell-
deficient (‘‘nude’’) mice have impaired immune responses, and are
unable to resolve malaria infections [2]. CD4z T cells play an
important role during the early stages of malarial infection, by
amplifying the phagocytic and cell-mediated antiparasite re-
sponses; later in the infection, they help B cells to produce
antibody, and assist in regulating the innate response [51–53].
Immune-mediated clearance of uRBCs was necessary to explain
the dynamics in all three phenotypes, but nude mice had the
higher maximum clearance rate of uRBCs. The infection rate of
RBCs with merozoites, as reflected in the parameter m^, could also
be higher in nude mice. As a simple proxy for the real biological
system, these results indicate that nude mice are less able to limit
the replication of the malaria parasite, and that their less specific
immune response is associated with greater destruction of
uninfected cells.
At the individual mouse level, there was no evidence for
immune-mediated clearance of merozoites. However, the cumu-
lative evidence over all mice suggests that it is required to explain
our data. Our interpretation of this result is that merozoite
clearance is weak during the first few weeks of infection, and that
pRBC and uRBC clearance are the major determinants of the
dynamics during this time. Previous models have shown that, for a
given level of immune activity, merozoite clearance is less effective
at controlling parasite density compared to an equivalent response
Figure 8. Parameter estimates. Marginal distributions of the fitted parameters for the baseline model. Histograms are for individual mice. Panels
with white backgrounds correspond to AJ-infected mice; panels with grey backgrounds correspond to AS-infected mice.
doi:10.1371/journal.pcbi.1000946.g008
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that clears pRBCs [7,8]. One explanation for this is that the
duration of the merozoite infection phase (estimated to be on the
order of minutes) is too short for the immune system to effectively
target merozoites [7]. However, there is no a priori reason that one
or several fast-acting, highly effective immune responses could not
operate during this phase. There is considerable empirical
evidence that merozoite surface protein one (MSP1) is a target
of immune mechanisms in malaria infections [54]. The presence of
high levels of naturally acquired IgG antibodies to merozoite
surface protein two (MSP2) is also strongly associated with
protection against clinical malaria [55]. Recent results suggest
that this naturally acquired protection is not specific in relation to
the major allelic dimorphisms of MSP2 [56].
We have shown that erythropoiesis upregulates during malarial
infection, and that wildtype and reconstituted mice have higher
upregulation than nude mice. This may reflect that the
erythropoietic response only upregulates to the extent that the
host is controlling the parasite. Recent theoretical results have
shown that excessive upregulation of erythropoiesis facilitates the
growth of the parasite, and may result in greater anaemia and a
higher peak of parasite density [57]. We also investigated whether
there is a time delay before the upregulation of erythropoiesis, and
a lag in the feedback between RBC density and the level of
erythropoiesis. The results for the AJ-infected wildtype mice
suggest that upregulation of erythropoiesis occurs from day 10.
Both reconstituted and nude mice show no evidence of a time
delay. Our results also suggest a time lag of 2–3 days in the
feedback between RBC density and erythropoiesis in AJ-infected
reconstituted mice; however there is no evidence for a time lag in
the other treatments. The reasons for this are unclear. One
possibility is that our putative time lag is compensating for another
process not included in the model. Only analysis of other data sets
may reveal what this may be.
In summary, our results show that the immune system plays a
key role in determining the RBC and parasite dynamics in
malaria-infected mice. We have shown that immune-mediated
clearance of both parasitised and unparasitised RBCs is necessary
to explain the RBC and parasite dynamics. Previous models have
examined the implications of RBC age structure for the infection
dynamics [14,22]. In particular, recent work by Mideo et al. (2008)
suggests that P. chabaudi may preferentially infect mature RBCs
(normocytes), but produce more merozoites in younger cells
(reticulocytes) [14]. Future models may need to consider how RBC
age structure and immune system dynamics can be combined to
obtain a more complete picture of the asexual stage of malaria.
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